The South Australian Health and Medical Research Institute (SAHMRI) is leading the development of Australia’s first proton therapy facility, The Australian Bragg Centre for Proton Therapy and Research (ABC). As part of its detailed preparation to deliver this new, life-saving treatment for children and adults with rare cancers, SAHMRI is consulting with its diverse national and international contacts in the radiation oncology sector.
If you can contribute to this innovative development, please contact email@example.com to register your interest in being part of the market consultation.
Proton therapy is the most precise form of radiation treatment for cancer, targeting tumours while reducing radiation to surrounding healthy tissues. This makes it an optimal treatment for people with cancers close to vulnerable organs and particularly for children.
Construction of the ABC building is underway and on target for completion in mid-2023, with treatments scheduled to begin 12-18 months later.
This world-class centre of excellence for cancer research and treatment will house a Radiance 330® Proton Therapy System, the same system that is currently operational at the Massachusetts General Hospital in Boston, USA.
The ABC is named for the renowned father-son team of physicists, Sir William Henry Bragg and Sir William Lawrence Bragg, whose work earned them the 1915 Nobel Prize for Physics. The Bragg peak phenomenon, which is at the heart of precision proton therapy, was discovered by Sir William Henry Bragg in Adelaide in 1905.
To register your interest in the market sounding process please contact:
Mr John Ranaldo
Chief Financial Officer, SAHMRI